BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 25003018)

  • 1. Alkaptonuria.
    Mistry JB; Bukhari M; Taylor AM
    Rare Dis; 2013; 1():e27475. PubMed ID: 25003018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ochronotic osteoarthropathy in a mouse model of alkaptonuria, and its inhibition by nitisinone.
    Preston AJ; Keenan CM; Sutherland H; Wilson PJ; Wlodarski B; Taylor AM; Williams DP; Ranganath LR; Gallagher JA; Jarvis JC
    Ann Rheum Dis; 2014 Jan; 73(1):284-9. PubMed ID: 23511227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitisinone Arrests but Does Not Reverse Ochronosis in Alkaptonuric Mice.
    Keenan CM; Preston AJ; Sutherland H; Wilson PJ; Psarelli EE; Cox TF; Ranganath LR; Jarvis JC; Gallagher JA
    JIMD Rep; 2015; 24():45-50. PubMed ID: 25940034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alkaptonuria: a very rare metabolic disorder.
    Aquaron R
    Indian J Biochem Biophys; 2013 Oct; 50(5):339-44. PubMed ID: 24772955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of antioxidant drugs for the treatment of ochronotic alkaptonuria in an in vitro human cell model.
    Tinti L; Spreafico A; Braconi D; Millucci L; Bernardini G; Chellini F; Cavallo G; Selvi E; Galeazzi M; Marcolongo R; Gallagher JA; Santucci A
    J Cell Physiol; 2010 Oct; 225(1):84-91. PubMed ID: 20648626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The human gene for alkaptonuria (AKU) maps to chromosome 3q.
    Janocha S; Wolz W; Srsen S; Srsnova K; Montagutelli X; Guénet JL; Grimm T; Kress W; Müller CR
    Genomics; 1994 Jan; 19(1):5-8. PubMed ID: 8188241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative stress and mechanisms of ochronosis in alkaptonuria.
    Braconi D; Millucci L; Bernardini G; Santucci A
    Free Radic Biol Med; 2015 Nov; 88(Pt A):70-80. PubMed ID: 25733348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homogentisic acid induces morphological and mechanical aberration of ochronotic cartilage in alkaptonuria.
    Bernardini G; Leone G; Millucci L; Consumi M; Braconi D; Spiga O; Galderisi S; Marzocchi B; Viti C; Giorgetti G; Lupetti P; Magnani A; Santucci A
    J Cell Physiol; 2019 May; 234(5):6696-6708. PubMed ID: 30341892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of an Effective Therapy for Alkaptonuria - Lessons for Osteoarthritis.
    Gallagher JA; Dillon JP; Ranganath LR
    Rheumatol Immunol Res; 2021 Jun; 2(2):79-85. PubMed ID: 36465977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A molecular spectroscopy approach for the investigation of early phase ochronotic pigment development in Alkaptonuria.
    Bernini A; Petricci E; Atrei A; Baratto MC; Manetti F; Santucci A
    Sci Rep; 2021 Nov; 11(1):22562. PubMed ID: 34799606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Raman Spectroscopy identifies differences in ochronotic and non-ochronotic cartilage; a potential novel technique for monitoring ochronosis.
    Taylor AM; Jenks DD; Kammath VD; Norman BP; Dillon JP; Gallagher JA; Ranganath LR; Kerns JG
    Osteoarthritis Cartilage; 2019 Aug; 27(8):1244-1251. PubMed ID: 31022456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ochronotic arthritis and ochronotic Achilles tendon rupture in alkaptonuria: A 6 years follow-up case report in China.
    Jiang L; Cao L; Fang J; Yu X; Dai X; Miao X
    Medicine (Baltimore); 2019 Aug; 98(34):e16837. PubMed ID: 31441856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alkaptonuria, ochronosis, and ochronotic arthropathy.
    Mannoni A; Selvi E; Lorenzini S; Giorgi M; Airó P; Cammelli D; Andreotti L; Marcolongo R; Porfirio B
    Semin Arthritis Rheum; 2004 Feb; 33(4):239-48. PubMed ID: 14978662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alkaptonuria in Russia.
    Soltysova A; Kuzin A; Samarkina E; Zatkova A
    Eur J Hum Genet; 2022 Feb; 30(2):237-242. PubMed ID: 34504318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Mimic of Ankylosing Spondylitis, Ochronosis: Case Report and Review of the Literature.
    Chu P; Cuellar MC; Bracken SJ; Tarrant TK
    Curr Allergy Asthma Rep; 2021 Mar; 21(3):19. PubMed ID: 33666743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Redox-proteomics of the effects of homogentisic acid in an in vitro human serum model of alkaptonuric ochronosis.
    Braconi D; Bianchini C; Bernardini G; Laschi M; Millucci L; Spreafico A; Santucci A
    J Inherit Metab Dis; 2011 Dec; 34(6):1163-76. PubMed ID: 21874298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calculi and intracellular ochronosis in the submandibular tissues from a patient with alkaptonuria.
    Taylor AM; Wilson PJ; Ingrams DR; Helliwell TR; Gallagher JA; Ranganath LR
    J Clin Pathol; 2010 Feb; 63(2):186-8. PubMed ID: 20154043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homogentisic acid induces autophagy alterations leading to chondroptosis in human chondrocytes: Implications in Alkaptonuria.
    Galderisi S; Milella MS; Rossi M; Cicaloni V; Rossi R; Giustarini D; Spiga O; Tinti L; Salvini L; Tinti C; Braconi D; Millucci L; Lupetti P; Prischi F; Bernardini G; Santucci A
    Arch Biochem Biophys; 2022 Mar; 717():109137. PubMed ID: 35090868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of an in vitro model to investigate joint ochronosis in alkaptonuria.
    Tinti L; Taylor AM; Santucci A; Wlodarski B; Wilson PJ; Jarvis JC; Fraser WD; Davidson JS; Ranganath LR; Gallagher JA
    Rheumatology (Oxford); 2011 Feb; 50(2):271-7. PubMed ID: 20952450
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.